Together is a new resource for anyone affected by pediatric cancer - patients and their parents, family members, and friends.Learn More
Mycophenolate mofetil, Mycophenolate sodium, Mycophenolic acid
Often used for:
Prevention of organ rejection after kidney, heart, or liver transplant; Graft vs. host disease (GVHD) after stem cell transplant
Mycophenolate (CellCept®, Myfortic®) is a medicine that suppresses the immune system (immunosuppressant). It is used to decrease the body’s natural immune system. Mycophenolate may be used prevent or treat GVHD in hematopoietic cell transplant. It may also be used to prevent rejection of organ transplants or to treat autoimmune diseases.
Female patients of childbearing age will be given a pregnancy test before starting this medicine. Patients will have regular blood draws to check blood counts and to monitor kidney and liver function. This drug may increase the risk of infection, especially in patients with a weak immune system.
May be taken as a tablet by mouth
May be taken as a capsule by mouth
May be taken as a liquid by mouth
May be given as a liquid into a vein by IV
Not all patients who take mycophenolate will experience these side effects. Common side effects are in bold, but there may be others. Please report all suspected side effects to your doctor or pharmacist.
Some patients may experience long-term or late effects of treatment that may continue or develop months or years after treatment ends. Possible late effects due to mycophenolate include:
Be sure to discuss these and other recommendations with your doctor or pharmacist.